Sector: Healthcare

Mid Cap

Molbio Diagnostics Share Price

Q: What is the current share price of Molbio Diagnostics Ltd.?

As of 8 October 2026 at 10:01 AM, the share price for Molbio Diagnostics Ltd. is ₹ 1433 on the NSE and ₹ 1428 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

Q: What is the Market Capitalization of Molbio Diagnostics Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 8 October 2026, the market cap for Molbio Diagnostics Ltd. is approximately ₹ 17046.3 Cr.

Q: What is the 52-Week High and Low for Molbio Diagnostics Ltd.?

Over the past 52 weeks, the highest price reached by Molbio Diagnostics Ltd. shares was ₹ 1686.8, and the lowest price was ₹ 926.35.

Q: Who are the major shareholders of Molbio Diagnostics Ltd.?

Significant shareholdings in Molbio Diagnostics Ltd. typically include entities such as: Promoter Public Other Institutions Mutual Funds FII (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Molbio Diagnostics Ltd. in the Healthcare sector?

In the Healthcare sector, Molbio Diagnostics Ltd. is often compared with other major players such as Manipal Health Enterprises, Avience Biomedicals, QLine Biotech, Hannah Joseph Hospital and Modern Diagnostic Research for analysis and benchmarking.

Q: What is the shareholding pattern for Molbio Diagnostics Ltd.?

As per the filings for the quarter ending Quarter, the approximate shareholding pattern for Molbio Diagnostics Ltd. is: Promoters: Promoter Holding (%)% Domestic Institutional Investors (DII): Holding (%)% Foreign Institutional Investors (FII): Holding (%)% Others (including Public): Holding (%)%

MOLBIO

₹1,433

-46.20(-3.12%)

BUY SELL

9th Oct 2026 | 3:28 PM

NSE : MOLBIO

Open Free Demat Account

Molbio Diagnostics Share Price Today

As of 12-10-2026 01:49, Molbio Diagnostics Ltd. share price today is ₹0, with a change of ₹-1479.20 (-100.00%) from the previous close of ₹1479.2. The stock opened at ₹1481.2 and traded between ₹1427.1 and ₹1488.9, with a total traded volume of 779885 shares. The company has a market capitalization of ₹17046.3 Cr in the Healthcare sector. while its 52-week high and low are ₹1686.8 and ₹926.35, respectively.

Molbio Diagnostics Ltd. valuation metrics include EPS of ₹14.77, and book value of ₹14.60. Profitability indicators show ROE of 14.24%.

Molbio Diagnostics Ltd. technical indicators include Day RSI at 62.79, Day MFI at 74.31, Day ADX at 39.05. Additional indicators include Commodity Channel Index (CCI) at 102.9 and Williams %R at -27.6. Momentum indicators show Day MACD at 94, Day MACD Signal Line at 80.43, DayATR at 105.35. Rate of Change indicators for Molbio Diagnostics Ltd. include ROC21 at 31.23.

Exponential moving averages include EMA5 at ₹1474.5, EMA10 at ₹1419.8, EMA12 at ₹1402.8, EMA20 at ₹1344.9, EMA26 at ₹1311.2. Simple moving averages include SMA5 at ₹1508.3, SMA10 at ₹1383.6, SMA20 at ₹1353.7, SMA30 at ₹1278.

Support levels for Molbio Diagnostics are placed at First Support ₹1425.67, Second Support ₹1372.13, Third Support ₹1293.07. Resistance levels are seen at First Resistance ₹1558.27, Second Resistance ₹1637.33, Third Resistance ₹1690.87. Molbio Diagnostics Ltd. shareholding pattern shows promoter holding at 41.29%, FII holding at 1.51%, DII holding at 0%, public holding at 40.83%.

Molbio Diagnostics Performance

Price Movement

₹1433.00

₹1427.10

₹1488.90

↘ Today's Low↗ Today's High

1 Year Performance

₹1433.00

₹926.35

₹1686.80

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹1,488.90

Low₹1,427.10

Open at₹1,481.20

Prev Close₹1,479.20

Volumes7.80 L

Avg Price₹1,455.21

Lower Circuit₹1,183.40

Upper Circuit₹1,775.00

Historical Performance

3M High₹1,686.80

3M Low₹926.35

1 Yr High₹1,686.80

1 Yr Low₹926.35

3 Yr High₹1,686.80

3 Yr Low₹926.35

5 Yr High₹1,686.80

5 Yr Low₹926.35

Molbio Diagnostics Fundamentals

Market Cap

High in industry

17,046.30 Cr.

PE Ratio (TTM)

Dividend Yield

Net Profit TTM

Net profit TTM

Net Profit Growth

Net profit TTM

PEG Ratio

ROE

5% decr over last year

14.24

Operating Revenue TTM

Operating Revenue Growth

Operating Revenue TTM

Book Value

High in industry

14.60

MFI

MFI Overbought

74.31

RSI

RSI is mid-range

62.79

EPS (TTM)

14.77

Debt to Equity

0.35

Face Value

Operating Profit Margin Qtr.

22.09

Operating Profit Qtr.

100.58

Net Profit Qtr.

58.75

Operating Revenue Qtr.

408.38

PB Ratio

14.60

Molbio Diagnostics Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Jun 2025
Total Revenue	399.38	438.71	95.32
Operating Expense	307.74	331.67	104.96
Operating Profit	91.64	107.04	-9.64
Depreciation	8.42	9.85	7.41
Interest	8.66	9.28	1.89
Tax	19.30	24.97	-4.06
Net Profit	56.63	65.69	-13.40

Molbio Diagnostics Technicals

Molbio Diagnostics Ltd. EMA & SMA

₹1433.00

-111.70 (-7.23%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1474.5

Day EMA10 ₹1419.8

Day EMA12 ₹1402.8

Day EMA20 ₹1344.9

Day EMA26 ₹1311.2

Molbio Diagnostics Support and Resistance

Resistance

First Resistance₹1558.27

Second Resistance₹1637.33

Third Resistance₹1690.87

Support

First Support₹1425.67

Second Support₹1372.13

Third Support₹1293.07

Technical Indicators

Day RSI62.79

Day MFI74.31

Day ADX39.05

Day Commodity Channel Index102.90

William-27.60

Day MACD94.00

Day MACD Signal Line80.43

Day ATR105.35

Day ROC125-

Day ROC2131.23

Molbio Diagnostics Shareholding Pattern

Held By
Promoter
FII
DII
Public

Molbio Diagnostics Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	9.34 L	25.83 L	36.15%
Week	4.61 L	21.73 L	21.20%
1 Month	9.19 L	51.6 L	17.81%
6 Month	2.58 L	13.09 L	19.75%

Molbio Diagnostics SWOT Analysis

Strengths14

Weakness5

Opportunity0

Threats0

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Stock gained more than 20% in one month

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Molbio Diagnostics Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Molbio Diagnostics Stock Comparison

Financials	Park Medi World Ltd.	Nephrocare Health Services Ltd.
Price (₹)	₹270.40	₹618.50
% Change	3.66%	-1.35%
Revenue TTM (₹ Cr)	₹1,756.29	₹1,052.82
Net Profit TTM (₹ Cr)	₹277.71	₹85.11
PE TTM	40.60	73.90
1 Year Return	61.02	36.29
ROCE	18.10	13.72